160 related articles for article (PubMed ID: 10982799)
41. p53 mediated apoptosis in HeLa cells: transcription dependent and independent mechanisms.
Haupt Y; Rowan S; Shaulian E; Kazaz A; Vousden K; Oren M
Leukemia; 1997 Apr; 11 Suppl 3():337-9. PubMed ID: 9209383
[TBL] [Abstract][Full Text] [Related]
42. Novel human p53 mutations that are toxic to yeast can enhance transactivation of specific promoters and reactivate tumor p53 mutants.
Inga A; Resnick MA
Oncogene; 2001 Jun; 20(26):3409-19. PubMed ID: 11423991
[TBL] [Abstract][Full Text] [Related]
43. Binding to the naturally occurring double p53 binding site of the Mdm2 promoter alleviates the requirement for p53 C-terminal activation.
Kaku S; Iwahashi Y; Kuraishi A; Albor A; Yamagishi T; Nakaike S; Kulesz-Martin M
Nucleic Acids Res; 2001 May; 29(9):1989-93. PubMed ID: 11328884
[TBL] [Abstract][Full Text] [Related]
44. Cyclin-dependent kinase inhibitors uncouple cell cycle progression from mitochondrial apoptotic functions in DNA-damaged cancer cells.
Le HV; Minn AJ; Massagué J
J Biol Chem; 2005 Sep; 280(36):32018-25. PubMed ID: 16002406
[TBL] [Abstract][Full Text] [Related]
45. A mutant P53 can activate apoptosis through a mechanism distinct from those induced by wild type P53.
He M; Rennie PS; Dragowska V; Nelson CC; Jia W
FEBS Lett; 2002 Apr; 517(1-3):151-4. PubMed ID: 12062426
[TBL] [Abstract][Full Text] [Related]
46. MCG10, a novel p53 target gene that encodes a KH domain RNA-binding protein, is capable of inducing apoptosis and cell cycle arrest in G(2)-M.
Zhu J; Chen X
Mol Cell Biol; 2000 Aug; 20(15):5602-18. PubMed ID: 10891498
[TBL] [Abstract][Full Text] [Related]
47. Hyaluronidase induction of a WW domain-containing oxidoreductase that enhances tumor necrosis factor cytotoxicity.
Chang NS; Pratt N; Heath J; Schultz L; Sleve D; Carey GB; Zevotek N
J Biol Chem; 2001 Feb; 276(5):3361-70. PubMed ID: 11058590
[TBL] [Abstract][Full Text] [Related]
48. Mutant p53 mediated induction of cell cycle arrest and apoptosis at G1 phase by 9-hydroxyellipticine.
Sugikawa E; Hosoi T; Yazaki N; Gamanuma M; Nakanishi N; Ohashi M
Anticancer Res; 1999; 19(4B):3099-108. PubMed ID: 10652599
[TBL] [Abstract][Full Text] [Related]
49. Targeted point mutations of p53 lead to dominant-negative inhibition of wild-type p53 function.
de Vries A; Flores ER; Miranda B; Hsieh HM; van Oostrom CT; Sage J; Jacks T
Proc Natl Acad Sci U S A; 2002 Mar; 99(5):2948-53. PubMed ID: 11867759
[TBL] [Abstract][Full Text] [Related]
50. Papillomavirus E2 induces p53-independent apoptosis in HeLa cells.
Desaintes C; Goyat S; Garbay S; Yaniv M; Thierry F
Oncogene; 1999 Aug; 18(32):4538-45. PubMed ID: 10467398
[TBL] [Abstract][Full Text] [Related]
51. COOH-terminal domain of p53 modulates p53-mediated transcriptional transactivation, cell growth, and apoptosis.
Zhou X; Wang XW; Xu L; Hagiwara K; Nagashima M; Wolkowicz R; Zurer I; Rotter V; Harris CC
Cancer Res; 1999 Feb; 59(4):843-8. PubMed ID: 10029073
[TBL] [Abstract][Full Text] [Related]
52. Apoptosis or senescence-like growth arrest: influence of cell-cycle position, p53, p21 and bax in H2O2 response of normal human fibroblasts.
Chen QM; Liu J; Merrett JB
Biochem J; 2000 Apr; 347(Pt 2):543-51. PubMed ID: 10749685
[TBL] [Abstract][Full Text] [Related]
53. Radiation-induced apoptosis is not enhanced by expression of either p53 or BAX in SW626 ovarian cancer cells.
Strobel T; Swanson L; Korsmeyer S; Cannistra SA
Oncogene; 1997 Jun; 14(23):2753-8. PubMed ID: 9190890
[TBL] [Abstract][Full Text] [Related]
54. The 7-amino-acid site in the proline-rich region of the N-terminal domain of p53 is involved in the interaction with FAK and is critical for p53 functioning.
Golubovskaya VM; Finch R; Zheng M; Kurenova EV; Cance WG
Biochem J; 2008 Apr; 411(1):151-60. PubMed ID: 18215142
[TBL] [Abstract][Full Text] [Related]
55. Bax/Bak activation in the absence of Bid, Bim, Puma, and p53.
Zhang J; Huang K; O'Neill KL; Pang X; Luo X
Cell Death Dis; 2016 Jun; 7(6):e2266. PubMed ID: 27310874
[TBL] [Abstract][Full Text] [Related]
56. Induction of apoptosis in HeLa cells by trans-activation-deficient p53.
Haupt Y; Rowan S; Shaulian E; Vousden KH; Oren M
Genes Dev; 1995 Sep; 9(17):2170-83. PubMed ID: 7657168
[TBL] [Abstract][Full Text] [Related]
57. Microglia-derived IL-1β triggers p53-mediated cell cycle arrest and apoptosis in neural precursor cells.
Guadagno J; Swan P; Shaikh R; Cregan SP
Cell Death Dis; 2015 Jun; 6(6):e1779. PubMed ID: 26043079
[TBL] [Abstract][Full Text] [Related]
58. Requirement of p53 targets in chemosensitization of colonic carcinoma to death ligand therapy.
Wang S; El-Deiry WS
Proc Natl Acad Sci U S A; 2003 Dec; 100(25):15095-100. PubMed ID: 14645705
[TBL] [Abstract][Full Text] [Related]
59. Aberrant p21 regulation in radioresistant primary glioblastoma multiforme cells bearing wild-type p53.
Kraus A; Gross MW; Knuechel R; Münkel K; Neff F; Schlegel J
J Neurosurg; 2000 Nov; 93(5):863-72. PubMed ID: 11059670
[TBL] [Abstract][Full Text] [Related]
60. Plumbagin (5-hydroxy-2-methyl-1,4-naphthoquinone) induces apoptosis and cell cycle arrest in A549 cells through p53 accumulation via c-Jun NH2-terminal kinase-mediated phosphorylation at serine 15 in vitro and in vivo.
Hsu YL; Cho CY; Kuo PL; Huang YT; Lin CC
J Pharmacol Exp Ther; 2006 Aug; 318(2):484-94. PubMed ID: 16632641
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
